"Preliminary Seroepidemiological survey of dengue infections in Pakistan, 2009-2014"
- PMID: 28274279
- PMCID: PMC5343310
- DOI: 10.1186/s40249-017-0258-6
"Preliminary Seroepidemiological survey of dengue infections in Pakistan, 2009-2014"
Abstract
Background: Dengue virus is the causative agent of dengue fever, a vector borne infection which causes self-limiting to life threatening disease in humans. A sero-epidemiological study was conducted to understand the current epidemiology of dengue virus in Pakistan which is now known as a dengue endemic country after its first reported outbreak in 1994.
Methods: To investigate the prevalence of dengue virus in Pakistan during 2009-2014, a total of 9,493 blood samples were screened for the detection of anti-dengue IgM antibodies using ELISA. Clinical and demographic features available with hospital records were reviewed to ascertain mortalities related to dengue hemorrhagic shock syndrome.
Results: Out of 9,493 samples tested, 37% (3,504) were found positive for anti-dengue IgM antibodies. Of the seropositive cases, 73.6% (2,578/3,504) were male and 26.4% (926/3,504) were female. The highest number (382/929; 41.1%) of sero-positive cases was observed among the individuals of age group 31-40 years. The highest number of symptomatic cases was reported in October (46%; 4,400/9,493), and the highest number of sero-positive cases among symptomatic cases was observed in November (45.7%; 806/1,764). Mean annual patient incidence (MAPI) during 2009-2014 in Pakistan remained 0.30 with the highest annual patient incidence (11.03) found in Islamabad. According to the available medical case record, 472 dengue related deaths were reported during 2009-2014.
Conclusion: The data from earlier reports in Pakistan described the dengue virus incidence from limited areas of the country. Our findings are important considering the testing of clinical samples at a larger scale covering patients of vast geographical regions and warrants timely implementation of dengue vector surveillance and control programs.
Trial registration number: It is an epidemiological research study, so trial registration is not required.
Keywords: Dengue Virus; IgM ELISA; Pakistan; Vector; epidemiology.
Figures
References
-
- WHO. Dengue, Guidelines for diagnosis, treatment, prevention and control. 2009. http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf?ua=1). Accessed 20 June 2016. - PubMed
-
- Garg A, Garg AJ, Rao YK, Upadhyay GC, Sakhuja S. Prevalence of dengue among clinically suspected febrile episodes at a Teaching Hospital in North India. J Infect Dis Immunol. 2011;3:85–89.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
